These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9487605)

  • 1. [Lispro-insulin analogs in therapy of diabetes].
    Rosenberger JS; Eibl N; Schernthaner G
    Wien Klin Wochenschr; 1997 Dec; 109(23):910-8. PubMed ID: 9487605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of insulin lispro in combination with NPH human insulin twice per day in patients with insulin-dependent or non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group.
    Vignati L; Anderson JH; Iversen PW
    Clin Ther; 1997; 19(6):1408-21. PubMed ID: 9444449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-meal insulin analogue insulin lispro vs Humulin R insulin treatment in young subjects with type 1 diabetes.
    Garg SK; Carmain JA; Braddy KC; Anderson JH; Vignati L; Jennings MK; Chase HP
    Diabet Med; 1996 Jan; 13(1):47-52. PubMed ID: 8741812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin lispro: a review of its pharmacological properties and therapeutic use in the management of diabetes mellitus.
    Wilde MI; McTavish D
    Drugs; 1997 Oct; 54(4):597-614. PubMed ID: 9339963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitus.
    Persson B; Swahn ML; Hjertberg R; Hanson U; Nord E; Nordlander E; Hansson LO
    Diabetes Res Clin Pract; 2002 Nov; 58(2):115-21. PubMed ID: 12213353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of postprandial versus interprandial blood glucose to HbA1c in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtime.
    Ciofetta M; Lalli C; Del Sindaco P; Torlone E; Pampanelli S; Mauro L; Chiara DL; Brunetti P; Bolli GB
    Diabetes Care; 1999 May; 22(5):795-800. PubMed ID: 10332684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining the role of insulin lispro in the management of postprandial hyperglycaemia in patients with type 2 diabetes mellitus.
    Giugliano D; Ceriello A; Razzoli E; Esposito K
    Clin Drug Investig; 2008; 28(4):199-210. PubMed ID: 18345710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes.
    Pfützner A; Küstner E; Forst T; Schulze-Schleppinghoff B; Trautmann ME; Haslbeck M; Schatz H; Beyer J
    Exp Clin Endocrinol Diabetes; 1996; 104(1):25-30. PubMed ID: 8750567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of blood glucose control in Type 1 diabetic patients treated with lispro and multiple NPH injections.
    Colombel A; Murat A; Krempf M; Kuchly-Anton B; Charbonnel B
    Diabet Med; 1999 Apr; 16(4):319-24. PubMed ID: 10220206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postprandial glycaemia after regular and lispro insulin in children and adolescents with diabetes.
    Rami B; Schober E
    Eur J Pediatr; 1997 Nov; 156(11):838-40. PubMed ID: 9392394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus.
    Burge MR; Waters DL; Holcombe JH; Schade DS
    J Clin Endocrinol Metab; 1997 Mar; 82(3):920-4. PubMed ID: 9062507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin lispro update.
    Meece JD; Campbell RK
    Diabetes Educ; 2002; 28(2):269-77. PubMed ID: 11924304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postprandial insulin lispro. A new therapeutic option for type 1 diabetic patients.
    Schernthaner G; Wein W; Sandholzer K; Equiluz-Bruck S; Bates PC; Birkett MA
    Diabetes Care; 1998 Apr; 21(4):570-3. PubMed ID: 9571344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal time of administration of insulin lispro. Importance of meal composition.
    Strachan MW; Frier BM
    Diabetes Care; 1998 Jan; 21(1):26-31. PubMed ID: 9538966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin lispro lowers postprandial glucose in prepubertal children with diabetes.
    Deeb LC; Holcombe JH; Brunelle R; Zalani S; Brink S; Jenner M; Kitson H; Perlman K; Spencer M
    Pediatrics; 2001 Nov; 108(5):1175-9. PubMed ID: 11694699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the short-acting insulin analogue lispro in intensive treatment of type 1 diabetes mellitus: importance of appropriate replacement of basal insulin and time-interval injection-meal.
    Del Sindaco P; Ciofetta M; Lalli C; Perriello G; Pampanelli S; Torlone E; Brunetti P; Bolli GB
    Diabet Med; 1998 Jul; 15(7):592-600. PubMed ID: 9686700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of insulin glulisine in Japanese patients with type 1 diabetes mellitus.
    Kawamori R; Kadowaki T; Ishii H; Iwasaki M; Iwamoto Y
    Diabetes Obes Metab; 2009 Sep; 11(9):891-9. PubMed ID: 19614947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A direct comparison of insulin aspart and insulin lispro in patients with type 1 diabetes.
    Plank J; Wutte A; Brunner G; Siebenhofer A; Semlitsch B; Sommer R; Hirschberger S; Pieber TR
    Diabetes Care; 2002 Nov; 25(11):2053-7. PubMed ID: 12401756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial.
    Bretzel RG; Nuber U; Landgraf W; Owens DR; Bradley C; Linn T
    Lancet; 2008 Mar; 371(9618):1073-84. PubMed ID: 18374840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic efficacy of preprandial administration of Lys(B28), Pro(B29) human insulin analog in IDDM patients. A comparison with human regular insulin during a three-meal test period.
    Jacobs MA; Keulen ET; Kanc K; Casteleijn S; Scheffer P; Devillé W; Heine RJ
    Diabetes Care; 1997 Aug; 20(8):1279-86. PubMed ID: 9250454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.